Magnesium, vitamin D status and mortality: results from US National Health and Nutrition Examination Survey (NHANES) 2001 to 2006 and NHANES III

BMC Medicine

Qi Dai¹  Douglas L Seidner²  Reid M Ness²  Martha J Shrubsole⁴  Shumin M Zhang⁵  Lisa B Signorello³  JoAnn E Manson³  Yiqing Song⁵  Xinqing Deng⁴ 

[1] Institute for Medicine and Public Health, Vanderbilt University Medical Center, Nashville, TN 37203, USA;Department of Medicine, Division of Gastroenterology, Vanderbilt School of Medicine, Nashville, TN 37232, USA;Department of Epidemiology, Harvard School of Public Health, Boston, MA 02115, USA;Department of Medicine, Division of Epidemiology, Vanderbilt University School of Medicine, Nashville, TN 37203, USA;Division of Preventive Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02115, USA

关键词: Cardiovascular diseases;    Colorectal cancer;    Mortality;    Parathyroid hormone;    Vitamin D deficiency;    Vitamin D insufficiency;    Serum 25-hydroxyvitamin D levels;    Magnesium intake;   

Others  :  856935
DOI  :  10.1186/1741-7015-11-187

 received in 2012-12-29, accepted in 2013-07-24,  发布年份 2013

【 摘 要 】

Background

Magnesium plays an essential role in the synthesis and metabolism of vitamin D and magnesium supplementation substantially reversed the resistance to vitamin D treatment in patients with magnesium-dependent vitamin-D-resistant rickets. We hypothesized that dietary magnesium alone, particularly its interaction with vitamin D intake, contributes to serum 25-hydroxyvitamin D (25(OH)D) levels, and the associations between serum 25(OH)D and risk of mortality may be modified by magnesium intake level.

Methods

We tested these novel hypotheses utilizing data from the National Health and Nutrition Examination Survey (NHANES) 2001 to 2006, a population-based cross-sectional study, and the NHANES III cohort, a population-based cohort study. Serum 25(OH)D was used to define vitamin D status. Mortality outcomes in the NHANES III cohort were determined by using probabilistic linkage with the National Death Index (NDI).

Results

High intake of total, dietary or supplemental magnesium was independently associated with significantly reduced risks of vitamin D deficiency and insufficiency respectively. Intake of magnesium significantly interacted with intake of vitamin D in relation to risk of both vitamin D deficiency and insufficiency. Additionally, the inverse association between total magnesium intake and vitamin D insufficiency primarily appeared among populations at high risk of vitamin D insufficiency. Furthermore, the associations of serum 25(OH)D with mortality, particularly due to cardiovascular disease (CVD) and colorectal cancer, were modified by magnesium intake, and the inverse associations were primarily present among those with magnesium intake above the median.

Conclusions

Our preliminary findings indicate it is possible that magnesium intake alone or its interaction with vitamin D intake may contribute to vitamin D status. The associations between serum 25(OH)D and risk of mortality may be modified by the intake level of magnesium. Future studies, including cohort studies and clinical trials, are necessary to confirm the findings.

【 授权许可】

   
2013 Deng et al.; licensee BioMed Central Ltd.

【 图 表 】

【 参考文献 】

• [1]Holick MF: Resurrection of vitamin D deficiency and rickets. J Clin Invest 2006, 116:2062-2072.
• [2]Zittermann A, Iodice S, Pilz S, Grant WB, Bagnardi V, Gandini S: Vitamin D deficiency and mortality risk in the general population: a meta-analysis of prospective cohort studies. Am J Clin Nutr 2012, 95:91-100.
• [3]Schottker B, Ball D, Gellert C, Brenner H: Serum 25-hydroxyvitamin D levels and overall mortality. A systematic review and meta-analysis of prospective cohort studies. Ageing Res Rev 2013, 12:708-718.
• [4]Melamed ML, Michos ED, Post W, Astor B: 25-hydroxyvitamin D levels and the risk of mortality in the general population. Arch Intern Med 2008, 168:1629-1637.
• [5]Pittas AG, Lau J, Hu FB, Dawson-Hughes B: The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Metab 2007, 92:2017-2029.
• [6]Mitri J, Muraru MD, Pittas AG: Vitamin D and type 2 diabetes: a systematic review. Eur J Clin Nutr 2011, 65:1005-1015.
• [7]Pittas AG, Nelson J, Mitri J, Hillmann W, Garganta C, Nathan DM, Hu FB, Dawson-Hughes B, Diabetes Prevention Program Research Group: Plasma 25-hydroxyvitamin D and progression to diabetes in patients at risk for diabetes: an ancillary analysis in the Diabetes Prevention Program. Diabetes Care 2012, 35:565-573.
• [8]Sun Q, Shi L, Rimm EB, Giovannucci EL, Hu FB, Manson JE, Rexrode KM: Vitamin D intake and risk of cardiovascular disease in US men and women. Am J Clin Nutr 2011, 94:534-542.
• [9]Leu M, Giovannucci E: Vitamin D: epidemiology of cardiovascular risks and events. Best Pract Res Clin Endocrinol Metab 2011, 25:633-646.
• [10]Giovannucci E: Epidemiological evidence for vitamin D and colorectal cancer. J Bone Miner Res 2007, 22:V81-V85.
• [11]Lee JE, Li H, Chan AT, Hollis BW, Lee IM, Stampfer MJ, Wu K, Giovannucci E, Ma J: Circulating levels of vitamin D and colon and rectal cancer: the Physicians’ Health Study and a meta-analysis of prospective studies. Cancer Prev Res (Phila) 2011, 4:735-743.
• [12]Huncharek M, Muscat J, Kupelnick B: Colorectal cancer risk and dietary intake of calcium, vitamin D, and dairy products: a meta-analysis of 26,335 cases from 60 observational studies. Nutr Cancer 2009, 61:47-69.
• [13]Manson JE, Mayne ST, Clinton SK: Vitamin D and prevention of cancer - ready for prime time? N Engl J Med 2011, 364:1385-1387.
• [14]Shapses SA, Manson JE: Vitamin D and prevention of cardiovascular disease and diabetes: why the evidence falls short. JAMA 2011, 305:2565-2566.
• [15]Grant WB: Effect of interval between serum draw and follow-up period on relative risk of cancer incidence with respect to 25-hydroxyvitamin D level: implications for meta-analyses and setting vitamin D guidelines. Dermatoendocrinol 2011, 3:199-204.
• [16]Grant WB: Effect of follow-up time on the relation between prediagnostic serum 25-hydroxyvitamin D and all-cause mortality rate. Dermatoendocrinol 2012, 4:198-202.
• [17]Manson JE, Bassuk SS, Lee IM, Cook NR, Albert MA, Gordon D, Zaharris E, Macfadyen JG, Danielson E, Lin J, Zhang SM, Buring JE: The VITamin D and OmegA-3 TriaL (VITAL): rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular disease. Contemp Clin Trials 2012, 33:159-171.
• [18]Mithal A, Wahl DA, Bonjour JP, Burckhardt P, Dawson-Hughes B, Eisman JA, El-Hajj Fuleihan G, Josse RG, Lips P, Morales-Torres J, IOF Committee of Scientific Advisors (CSA) Nutrition Working Group: Global vitamin D status and determinants of hypovitaminosis D. Osteoporos Int 2009, 20:1807-1820.
• [19]International Agency for Research on Cancer: Vitamin D and Cancer - a report of the IARC working group on vitamin D. Lyon, France: World Health Organization Press; 2008.
• [20]Garland CF, French CB, Baggerly LL, Heaney RP: Vitamin D supplement doses and serum 25-hydroxyvitamin D in the range associated with cancer prevention. Anticancer Res 2011, 31:607-611.
• [21]Reddy V, Sivakumar B: Magnesium-dependent vitamin-D-resistant rickets. Lancet 1974, 1:963-965.
• [22]Risco F, Traba ML: Influence of magnesium on the in vitro synthesis of 24,25-dihydroxyvitamin D3 and 1 alpha, 25-dihydroxyvitamin D3. Magnes Res 1992, 5:5-14.
• [23]Rude RK, Adams JS, Ryzen E, Endres DB, Niimi H, Horst RL, Haddad JG Jr, Singer FR: Low serum concentrations of 1,25-dihydroxyvitamin D in human magnesium deficiency. J Clin Endocrinol Metab 1985, 61:933-940.
• [24]Risco F, Traba ML: Possible involvement of a magnesium dependent mitochondrial alkaline phosphatase in the regulation of the 25-hydroxyvitamin D3-1 alpha-and 25-hydroxyvitamin D3-24R-hydroxylases in LLC-PK1 cells. Magnes Res 1994, 7:169-178.
• [25]Rosler A, Rabinowitz D: Magnesium-induced reversal of vitamin-D resistance in hypoparathyroidism. Lancet 1973, 1:803-804.
• [26]Sahota O, Mundey MK, San P, Godber IM, Hosking DJ: Vitamin D insufficiency and the blunted PTH response in established osteoporosis: the role of magnesium deficiency. Osteoporos Int 2006, 17:1013-1021.
• [27]Fuss M, Bergmann P, Bergans A, Bagon J, Cogan E, Pepersack T, Van Gossum M, Corvilain J: Correction of low circulating levels of 1,25-dihydroxyvitamin D by 25-hydroxyvitamin D during reversal of hypomagnesaemia. Clin Endocrinol (Oxf) 1989, 31:31-38.
• [28]Freedman DM, Looker AC, Abnet CC, Linet MS, Graubard BI: Serum 25-hydroxyvitamin D and cancer mortality in the NHANES III study (1988–2006). Cancer Res 2010, 70:8587-8597.
• [29]Michos ED, Reis JP, Post WS, Lutsey PL, Gottesman RF, Mosley TH, Sharrett AR, Melamed ML: 25-Hydroxyvitamin D deficiency is associated with fatal stroke among whites but not blacks: the NHANES-III linked mortality files. Nutrition 2012, 28:367-371.
• [30][No authors listed]: Plan and operation of the Third National Health and Nutrition Examination Survey, 1988–94. Series 1: programs and collection procedures. Vital Health Stat 1 1994, 1-407.
• [31]Centers for Disease Control and Prevention: The National Health and Nutritional Examination Survey (NHANES) Analytic and Reporting Guidelines. Atlanta, GA: CDC; 2006.
• [32]Centers for Disease Control and Prevention: The National Health and Nutrition Examination Survey Laboratory Procedure Manual Serum 25-Hydroxyvitamin D Diasorin (formerly Incstar) 25-OH-D assay. Atlanta, GA: CDC; 2008.
• [33]Committee to Review Dietary Reference Intakes for Vitamin D and Calcium IoM: Implications and Special Concerns: Conclusions About Vitamin D Deficiency in the United States and Canada. In Dietary Reference Intakes for Calcium and Vitamin D. Washington, DC: National Academies Press; 2011:487.
• [34]Centers for Disease Control and Prevention: The National Health and Nutritiona Examination Survey Documentation, Codebook, and Frequencies; Dietary Interview - Individual Foods, First Day. Atlanta, GA: CDC; 2008.
• [35]Standing Committee on the Scientific Evaluation of Dietary Reference Intakes FaNBIoM: Dietary Reference Intakes. In Dietary Reference Intakes for Calcium, Phosphorus, Magnesium, Vitamin D, and Fluoride. Washington, DC: National Academy Press; 17.
• [36]Tretli S, Schwartz GG, Torjesen PA, Robsahm TE: Serum levels of 25-hydroxyvitamin D and survival in Norwegian patients with cancer of breast, colon, lung, and lymphoma: a population-based study. Cancer Causes Control 2012, 23:363-370.
• [37]Sakaki T, Kagawa N, Yamamoto K, Inouye K: Metabolism of vitamin D3 by cytochromes P450. Front Biosci 2005, 10:119-134.
• [38]Wang TJ, Jea ZFR: Common genetic determinants of vitamin D insufficiency: a genome-wide association study. Lancet 2010, 376:180-188.
• [39]Horsting M, Deluca HF: In vitro production of 25-hydroxycholecalciferol. Biochem Biophys Res Commun 1969, 36:251-256.
• [40]Haddad JG, Matsuoka LY, Hollis BW, Hu YZ, Wortsman J: Human plasma transport of vitamin D after its endogenous synthesis. J Clin Invest 1993, 91:2552-2555.
• [41]Gutierrez OM, Farwell WR, Kermah D, Taylor EN: Racial differences in the relationship between vitamin D, bone mineral density, and parathyroid hormone in the National Health and Nutrition Examination Survey. Osteoporos Int 2011, 22:1745-1753.
• [42]Larsson SC, Orsini N, Wolk A: Dietary magnesium intake and risk of stroke: a meta-analysis of prospective studies. Am J Clin Nutr 2012, 95:362-366.
• [43]Song Y, Manson JE, Cook NR, Albert CM, Buring JE, Liu S: Dietary magnesium intake and risk of cardiovascular disease among women. Am J Cardiol 2005, 96:1135-1141.
• [44]Zhang W, Iso H, Ohira T, Date C, Tamakoshi A: Associations of dietary magnesium intake with mortality from cardiovascular disease: the JACC study. Atherosclerosis 2012, 221:587-595.
• [45]Dai Q, Shrubsole MJ, Ness RM, Schlundt D, Cai Q, Smalley WE, Li M, Shyr Y, Zheng W: The relation of magnesium and calcium intakes and a genetic polymorphism in the magnesium transporter to colorectal neoplasia risk. Am J Clin Nutr 2007, 86:743-751.